Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
51 hedge funds and large institutions have $245M invested in Entellus Medical, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$82.3M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
+$75.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.6M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$12.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$6.35M |
Top Sellers
ENTL Hedge Fund Activity: Q1 2015 in Review
51 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q1 2015, worth a combined $245M.
Buyers outnumbered sellers: 51 funds opened new ENTL positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Essex Woodlands Management, opening a new position worth an estimated $82.3M.
- 51 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $245M of Entellus Medical, Inc. Common Stock stock for Q1 2015.
- 51 funds opened new Entellus Medical, Inc. Common Stock positions in Q1 2015 and 0 closed out, a net change of +51 holders.
- The largest Entellus Medical, Inc. Common Stock buyer in Q1 2015 was Essex Woodlands Management, an estimated $82.3M added.
Based on aggregated 13F filings for Q1 2015.